Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Cash from Investing Activities (2012 - 2026)

Iqvia Holdings' (IQV) quarterly Cash from Investing Activities came in at -$381.0 million in Q2 2026, down 10.12% year-over-year from -$423.9 million in Q2 2025, and down 94.39% quarter-over-quarter from -$196.0 million in Q1 2026.

Analysis

Iqvia Holdings (IQV) Cash from Investing Activities (2012 - 2026) Analysis & Trends

Iqvia Holdings has disclosed Cash from Investing Activities across 15 years of filings, most recently posting -$381.0 million for Q2 2026.

  • In Q2 2026, Cash from Investing Activities fell 10.12% year-over-year to -$381.0 million; the TTM figure through Jun 2026 stood at -$2.2 billion (down 43.01% YoY), while the FY2025 annual figure was -$2.3 billion, down 59.63% from the prior year.
  • Cash from Investing Activities came in at -$381.0 million for Q2 2026 at Iqvia Holdings, down from -$196.0 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$196.0 million in Q1 2026 to a low of -$1.1 billion in Q4 2025.
  • Average Cash from Investing Activities over 5 years is -$440.8 million, with a median of -$363.5 million recorded in 2025.
  • Year-over-year, Cash from Investing Activities jumped 63.78% in 2023 and plunged 256.13% in 2025.
  • Over 5 years, Cash from Investing Activities stood at -$477.0 million in 2022, then soared by 55.56% to -$212.0 million in 2023, then slumped by 46.23% to -$310.0 million in 2024, then sank by 256.13% to -$1.1 billion in 2025, then soared by 65.49% to -$381.0 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were -$381.0 million in Q2 2026, -$196.0 million in Q1 2026, and -$1.1 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -381.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn -23.89 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -108.34 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 28.10 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -7.00 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 11.09 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -55,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -55,941.69
10 VivoSim Labs 1.37 Mn 1.37 Mn - -23,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -381.00 Mn
Mar 31, 2026 -196.00 Mn
Dec 31, 2025 -1.10 Bn
Sep 30, 2025 -550.00 Mn
Jun 30, 2025 -346.00 Mn
Mar 31, 2025 -305.00 Mn
Dec 31, 2024 -310.00 Mn
Sep 30, 2024 -599.00 Mn
Jun 30, 2024 -221.00 Mn
Mar 31, 2024 -314.00 Mn
Dec 31, 2023 -212.00 Mn
Sep 30, 2023 -573.00 Mn
Jun 30, 2023 -596.00 Mn
Mar 31, 2023 -222.00 Mn
Dec 31, 2022 -477.00 Mn
Sep 30, 2022 -717.00 Mn
Jun 30, 2022 -199.00 Mn
Mar 31, 2022 -613.00 Mn
Dec 31, 2021 -647.00 Mn
Sep 30, 2021 -1.10 Bn